D37 COPD: DEVELOPMENTAL THERAPEUTICS: A Phase I, Randomised, Double Blind, Placebo Controlled, Study To Assess The Safety, Tolerability And Pharmacokinetics Of Multiple Inhaled Doses Of Rpl554 Administered By Nebuliser To Healthy Male Subjects And Stable COPD Patients
Singh, D, Abbott-Banner, K H, Reid, F, Newman, K
Published in American journal of respiratory and critical care medicine (01.01.2016)
Get full text
Published in American journal of respiratory and critical care medicine (01.01.2016)
Journal Article
D37 COPD: DEVELOPMENTAL THERAPEUTICS: A Phase I, Randomised, Double Blind, Placebo Controlled, Study To Assess The Safety, Tolerability And Pharmacokinetics Of Single Inhaled Doses Of The Dual Phosphodiesterase 3/4 (pde3/4) Inhibitor Rpl554 Administered By Nebuliser To Healthy Male Subjects
Singh, D, Abbott-Banner, K H, Reid, F, Newman, K
Published in American journal of respiratory and critical care medicine (01.01.2016)
Get full text
Published in American journal of respiratory and critical care medicine (01.01.2016)
Journal Article
A31 ASTHMA THERAPY: GLUCOCORTICOIDS AND BEYOND: Rpl554, A First-In-Class Dual Phosphodiesterase (pde)3/4 Inhibitor, Is Equi-Effective As A Bronchodilator To Maximal Doses Of Salbutamol In Asthmatics But With Fewer Adverse Events
Bjermer, L, Stewart, J, Abbott-Banner, K H, Newman, K
Published in American journal of respiratory and critical care medicine (01.01.2016)
Get full text
Published in American journal of respiratory and critical care medicine (01.01.2016)
Journal Article
Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls
Lea, Simon R, Metcalfe, Hannah J, Plumb, Jonathan, Beerli, Christian, Poll, Chris, Singh, Dave, Abbott-Banner, Katharine H
Published in International journal of chronic obstructive pulmonary disease (01.01.2016)
Published in International journal of chronic obstructive pulmonary disease (01.01.2016)
Get full text
Journal Article